Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 134,224 | 121,984 | 114,802 | 117,549 | 119,839 |
| Cost of Goods | 58,598 | 54,757 | 53,705 | 54,216 | 60,180 |
| Gross Profit | 75,626 | 67,227 | 61,097 | 63,333 | 59,659 |
| Operating Expenses | 25,212 | 25,186 | 26,921 | 25,226 | 20,201 |
| Operating Income | 51,012 | 42,798 | 34,881 | 38,323 | 39,638 |
| Interest Expense | 1,675 | 1,834 | 1,975 | 2,879 | 3,499 |
| Other Income | -1,822 | -867 | 544 | -731 | 610 |
| Pre-tax Income | 47,515 | 40,097 | 33,450 | 34,713 | 36,749 |
| Income Tax | 11,087 | 5,878 | 6,546 | -77,183 | 840 |
| Net Income Continuous | 36,428 | 34,219 | 26,904 | 111,896 | 35,909 |
| Net Income | $36,428 | $34,219 | $26,904 | $111,896 | $35,909 |
| EPS Basic Total Ops | 0.15 | 0.14 | 0.11 | 0.48 | 0.15 |
| EPS Basic Continuous Ops | 0.15 | 0.14 | 0.11 | 0.48 | 0.15 |
| EPS Diluted Total Ops | 0.15 | 0.14 | 0.11 | 0.45 | 0.15 |
| EPS Diluted Continuous Ops | 0.15 | 0.14 | 0.11 | 0.46 | 0.15 |
| EPS Diluted Before Non-Recurring Items | 0.16 | 0.15 | 0.14 | 0.14 | 0.15 |
| EBITDA(a) | $53,169 | $44,981 | $37,004 | $40,450 | $41,794 |